[Benefits of a thickened infant formula with lactase activity in the management of benign digestive disorders in newborns].
This study aimed at evaluating the interest of a thickened infant formula with lactase activity by comparison with a standard infant formula in the management of benign digestive disorders in infants. Infants of both sex (N =109), ranging in age from 0 to 3 months, were included in a randomised double blind trial. Infants went to the paediatrician because of benign digestive disorders such as regurgitation, eructation or hiccup, colic, persistent crying and/or meteorism. Nine hundred and three infants were included and randomised in two parallel groups: they consumed daily either the thickened infant formula with lactase activity or a standard infant formula. There were no significant difference in the infants included in both groups. Both formula were well accepted and tolerated. Growth of the infants and compliance during the study were identical and good in the two groups. The efficiency of the formula tested was showed on digestive symptoms through: a decrease of the intensity of the digestive discomforts more important in the test than in the standard formula group; a decrease of the intensity of the gaz significantly more important in the test than in the standard formula group; significant decreases in frequency and intensity of the gaz in the test group while there were no significant diminution in the standard group; This study showed the good tolerance, acceptability and efficiency of a thickened infant formula with lactase activity on benign digestive disorders of young infants.
Roy
P
P
Blédina, Villefranche sur Saône, France.
Aubert-Jacquin
C
C
Avart
C
C
Gontier
C
C
D019587:Dietary Supplements; D004066:Digestive System Diseases / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007225:Infant Food; D007231:Infant, Newborn; D043322:Lactase / Q000008:administration & dosage* / Q000627:therapeutic use*
D043322:Lactase